The National Institute for Health and Care Excellence (NICE) has published updated manuals for methods, processes and topic selection for Health Technology Assessments (HTA). This includes changes to how NICE...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
On World Evidence-Based Healthcare Day (20th October 2021), we explore the role of evidence in an infodemic and how evidence generation processes have been accelerated to offer rapid yet robust...
Read More
Are you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could...
Read More
Calum Jones, Consultant Health Economist at Mtech Access, shares his passion for helping MedTech firms build health economic models that help their innovative new technologies reach patients. Tell us about...
Read More
We are delighted to bring you our Pharma Market Access Insights Podcast. In this podcast we will offer insights and thought leadership from the market access and HEOR experts at Mtech...
Read More
Partitioned survival analysis (PartSA) is currently the most commonly used modelling approach within HTA (health technology assessment) for advanced or metastatic cancers. However, until recently, there was no formal documentation...
Read More
This video demonstrates the features and functions of a typical iPad budget impact model. This particular example looks at a health economic impact model running in the Veeva platform and...
Read More
